Press Releases Year None20202019 Apr 07, 2020 Zentalis Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Apr 02, 2020 Zentalis Pharmaceuticals Announces Pricing of Initial Public Offering Jan 09, 2020 Zentalis Pharmaceuticals Appoints David Johnson to Board of Directors Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Displaying 11 - 13 of 13
Apr 07, 2020 Zentalis Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares